ZYUS Life Sciences
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
407 Downey Rd 204, Saskatoon, Saskatchew...Phone Number
(888) 651-9987Website
www.zyus.comRevenue
<$5 MillionStock Symbol
ZYUSIndustry
About ZYUS Life Sciences
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates for medical and adult recreational. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2a clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. It operates in Canada, the United States, Australia, and the European Union. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.Explore more
ZYUS Life Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to ZYUS Life Sciences
Compare insights from companies similar to ZYUS Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ZYUS Life Sciences Tech Stack
A closer look at the technologies used by ZYUS Life Sciences
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding ZYUS Life Sciences
Sign Up For FreeTo access detailed company insights
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates for medical and adult recreational. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2a clinical trial for the treatment of chronic pain in adults caused due to musc... Read More
